4.10
전일 마감가:
$4.12
열려 있는:
$4.1
하루 거래량:
83,044
Relative Volume:
0.53
시가총액:
$172.65M
수익:
$52.84M
순이익/손실:
$-11.11M
주가수익비율:
-14.95
EPS:
-0.2742
순현금흐름:
$-9.12M
1주 성능:
+4.59%
1개월 성능:
-8.69%
6개월 성능:
+1.99%
1년 성능:
+114.66%
Apyx Medical Corp Stock (APYX) Company Profile
명칭
Apyx Medical Corp
전화
(727) 384-2323
주소
5115 ULMERTON ROAD, CLEARWATER, FL
Compare APYX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
APYX
Apyx Medical Corp
|
4.10 | 163.81M | 52.84M | -11.11M | -9.12M | -0.2742 |
|
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Apyx Medical Corp Stock (APYX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-11 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-12-16 | 개시 | Roth Capital | Buy |
| 2025-11-14 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-11-12 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2024-10-17 | 개시 | BTIG Research | Neutral |
| 2023-07-14 | 개시 | Stephens | Overweight |
| 2022-05-20 | 개시 | Lake Street | Buy |
| 2019-04-02 | 재확인 | Dougherty & Company | Buy |
모두보기
Apyx Medical Corp 주식(APYX)의 최신 뉴스
Apyx Medical CEO and CFO to Hold Aug. 11 Investor Fireside Chat - Stock Titan
Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference - The Manila Times
Apyx Medical Corp (APYX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Apyx Medical Corp (APYX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Apyx Medical Corp (APYX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
APYX|Apyx Medical Corp|Price:3.850|Chg%:-0.070 - TradingKey
Apyx Medical Corp (APYX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Apyx Medical Corp (APYX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Apyx Medical Corp (APYX) Balance Sheet - TradingKey
Apyx Medical Corp (APYX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
APYX|Apyx Medical Corp|Price:3.920|Chg%:+0.090 - TradingKey
Why is DeFi Development Corp. (DFDV) Betting on Apyx - Kavout | AI
Apyx Medical Corporation Reconstitutes Board Committees – SEC 8-K Filing Details, July 24, 2026 - Minichart
Apyx Medical Corp (APYX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Apyx Medical Schedules Live Q&A on Second-Quarter Results Aug. 6 - Stock Titan
Royce & Associates (APYX) reports 3.27M Apyx Medical shares under Schedule 13G/A - Stock Titan
This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
APYX Initiates Coverage On by HC Wainwright & Co. -- Price Targe - GuruFocus
Apyx Medical (APYX) director nets 6,976 shares from 12,000-option exercise and share withholding - Stock Titan
APYXApyx Medical Corp Volatility & Greeks - Finviz
Apyx Medical (NASDAQ: APYX) details 2026 votes on directors, pay and new incentive plan - Stock Titan
Apyx Medical Corp (APYX) Institutional Confidence - TradingKey
Form DEF 14A Apyx Medical Inc For: 23 June By Investing.com - Investing.com Australia
Apyx Medical Shares Rise on Promising Cellulite Treatment DataDividend Increase Stocks - dars.gov.et
Apyx Medical Corporation (APYX): a High Growth Micro-Cap Stock Improving Cellulite and Skin laxity - Insider Monkey
Apyx Medical Corp (APYX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Apyx Medical (NASDAQ: APYX) COO nets 4,467 shares after option exercise - Stock Titan
Apyx Medical (NASDAQ: APYX) adds Executive Chairman, awards 450,000 RSUs - Stock Titan
Apyx Medical (NASDAQ: APYX) director receives grant of 50,000 stock options - Stock Titan
Apyx Medical (APYX) CFO awarded 132,066 stock options at $4.65 - Stock Titan
Apyx Medical (APYX) Sr. VP granted 63,392 stock options at $4.65 strike - Stock Titan
Apyx Medical (NASDAQ: APYX) director awarded 450,000 restricted stock units - Stock Titan
Apyx Medical (NASDAQ: APYX) CEO awarded 213,948 stock options - Stock Titan
Apyx Medical (NASDAQ: APYX) COO awarded stock options on 88,044 shares - Stock Titan
[Form 4] Apyx Medical Corp Insider Trading Activity - Stock Titan
Apyx Medical (NASDAQ: APYX) director receives 50,000 stock options at $4.65 strike - Stock Titan
Apyx Medical Corp. Hits New 52-Week High of $4.65 - MarketsMojo
Apyx Medical Corp. Hits New 52-Week High of $4.97, Up 198% - MarketsMojo
How The Apyx Medical (APYX) Story Is Shifting With AYON, GLP 1 Demand And 2026 Goals - Yahoo Finance
Apyx Medical Corporation (APYX) Slips 3.73% as Stock Approaches Key Support LevelTotal Put Call - dars.gov.et
Apyx Medical Shares Rise 6% as Body-Contouring Push Hits New Milestone - Bez Kabli
Real Renuvion patients hit the runway in Apyx’s Miami Swim Week show - Stock Titan
Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway - PR Newswire
APYX Q1 2026 Earnings: EPS Beats Expectations Despite Revenue UncertaintyEarnings Momentum Score - The Legal Advocate
APYX Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Surprise But Stock DeclinesROIC Trend Report - The Legal Advocate
APYX Technical Analysis | Trend, Signals & Chart Patterns | APYX MEDICAL CORP (NASDAQ:APYX) - ChartMill
New Apyx Medical (APYX) data backs Avéli and Renuvion cellulite treatment - Stock Titan
Apyx Medical reports clinical data on cellulite treatment - Investing.com
One-session cellulite study shows visible dimple reduction, tighter skin - Stock Titan
APYX Stock Price, Quote & Chart | APYX MEDICAL CORP (NASDAQ:APYX) - ChartMill
Apyx Medical Corp (APYX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Apyx Medical Corp 주식 (APYX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Roman Shawn David | Chief Operating Officer |
Jun 15 '26 |
Option Exercise |
3.23 |
15,000 |
48,450 |
15,000 |
| CITRONOWICZ MOSHE | Senior Vice President |
Mar 15 '26 |
Option Exercise |
1.80 |
37,000 |
66,600 |
493,504 |
| Roman Shawn David | Chief Operating Officer |
Jan 27 '26 |
Option Exercise |
1.80 |
12,000 |
21,600 |
12,000 |
자본화:
|
볼륨(24시간):